Citigroup Lowers Agilon Health (NYSE:AGL) Price Target to $0.75

Agilon Health (NYSE:AGL) had its target price dropped by equities researchers at Citigroup from $0.85 to $0.75 in a note issued to investors on Tuesday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. Citigroup’s target price suggests a potential upside of 7.88% from the company’s current price.

A number of other research analysts have also recently issued reports on the company. Barclays cut their price objective on Agilon Health from $1.00 to $0.50 and set an “underweight” rating for the company in a report on Friday, February 27th. Wells Fargo & Company increased their target price on shares of Agilon Health from $1.00 to $1.50 and gave the stock an “overweight” rating in a research report on Friday, February 27th. Royal Bank Of Canada upgraded shares of Agilon Health from a “hold” rating to a “moderate buy” rating in a research report on Wednesday, December 3rd. BTIG Research reaffirmed a “neutral” rating on shares of Agilon Health in a research note on Friday, December 12th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Agilon Health in a report on Wednesday, January 21st. Three research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $2.18.

Agilon Health Stock Up 22.5%

NYSE AGL opened at $0.70 on Tuesday. Agilon Health has a 1-year low of $0.34 and a 1-year high of $6.08. The company has a market capitalization of $288.42 million, a price-to-earnings ratio of -0.73 and a beta of 0.11. The stock’s 50 day moving average is $0.71 and its two-hundred day moving average is $0.84. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12.

Agilon Health (NYSE:AGL) last posted its earnings results on Wednesday, February 25th. The company reported ($0.46) EPS for the quarter, missing the consensus estimate of ($0.27) by ($0.19). The company had revenue of $1.57 billion for the quarter, compared to the consensus estimate of $1.46 billion. Agilon Health had a negative return on equity of 120.82% and a negative net margin of 6.60%. Equities analysts forecast that Agilon Health will post -0.59 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Agilon Health

Hedge funds have recently added to or reduced their stakes in the stock. AQR Capital Management LLC boosted its holdings in shares of Agilon Health by 243.3% in the first quarter. AQR Capital Management LLC now owns 501,440 shares of the company’s stock valued at $2,171,000 after buying an additional 355,365 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in Agilon Health by 3.5% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 214,200 shares of the company’s stock valued at $927,000 after acquiring an additional 7,209 shares in the last quarter. Dynamic Technology Lab Private Ltd boosted its position in Agilon Health by 28.4% during the 1st quarter. Dynamic Technology Lab Private Ltd now owns 47,111 shares of the company’s stock worth $204,000 after acquiring an additional 10,424 shares during the last quarter. Goldman Sachs Group Inc. grew its stake in shares of Agilon Health by 6.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 5,060,333 shares of the company’s stock worth $21,911,000 after acquiring an additional 311,158 shares in the last quarter. Finally, Versor Investments LP acquired a new stake in shares of Agilon Health in the second quarter valued at approximately $320,000.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.